ATE31410T1 - Aryloxypropanolaminderivate, verfahren zu deren herstellung, pharmazeutische praeparate und therapeutische anwendung. - Google Patents

Aryloxypropanolaminderivate, verfahren zu deren herstellung, pharmazeutische praeparate und therapeutische anwendung.

Info

Publication number
ATE31410T1
ATE31410T1 AT84100085T AT84100085T ATE31410T1 AT E31410 T1 ATE31410 T1 AT E31410T1 AT 84100085 T AT84100085 T AT 84100085T AT 84100085 T AT84100085 T AT 84100085T AT E31410 T1 ATE31410 T1 AT E31410T1
Authority
AT
Austria
Prior art keywords
hydrogen
lower alkyl
halogen
aryloxypropanolam
derivatives
Prior art date
Application number
AT84100085T
Other languages
English (en)
Inventor
Cesare Casagrande
Massimo Nicola
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Application granted granted Critical
Publication of ATE31410T1 publication Critical patent/ATE31410T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
AT84100085T 1983-01-21 1984-01-06 Aryloxypropanolaminderivate, verfahren zu deren herstellung, pharmazeutische praeparate und therapeutische anwendung. ATE31410T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19219/83A IT1193608B (it) 1983-01-21 1983-01-21 Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
EP84100085A EP0116825B1 (de) 1983-01-21 1984-01-06 Aryloxypropanolaminderivate, Verfahren zu deren Herstellung, pharmazeutische Präparate und therapeutische Anwendung

Publications (1)

Publication Number Publication Date
ATE31410T1 true ATE31410T1 (de) 1988-01-15

Family

ID=11155887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84100085T ATE31410T1 (de) 1983-01-21 1984-01-06 Aryloxypropanolaminderivate, verfahren zu deren herstellung, pharmazeutische praeparate und therapeutische anwendung.

Country Status (6)

Country Link
US (1) US4579861A (de)
EP (1) EP0116825B1 (de)
JP (1) JPS59139362A (de)
AT (1) ATE31410T1 (de)
DE (1) DE3468104D1 (de)
IT (1) IT1193608B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135487A (en) 2000-04-05 2005-07-25 Cupron Corp Antimicrobial and antiviral polymeric materials and a process for preparing the same
US7296690B2 (en) 2002-04-18 2007-11-20 The Cupron Corporation Method and device for inactivating viruses
US7364756B2 (en) 2003-08-28 2008-04-29 The Cuprin Corporation Anti-virus hydrophilic polymeric material
US7480393B2 (en) 2003-11-19 2009-01-20 Digimarc Corporation Optimized digital watermarking functions for streaming data
EP1809385B1 (de) 2004-11-09 2009-07-15 The Cupron Corporation Verfahren und materialien für die hautpflege
WO2011115763A1 (en) * 2010-03-15 2011-09-22 The Trustees Of The University Of Pennsylvania Inhibitors of the tumor necrosis factor receptor complex
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DK193181A (da) * 1980-06-05 1981-12-06 Hoffmann La Roche Fremgangmaade til fremstilling af imidazolderivater
US4319032A (en) * 1980-06-06 1982-03-09 Alcolac Inc. Derivatives of aminoalkyl alkylene ureas

Also Published As

Publication number Publication date
EP0116825A1 (de) 1984-08-29
JPS59139362A (ja) 1984-08-10
IT8319219A0 (it) 1983-01-21
DE3468104D1 (en) 1988-01-28
IT1193608B (it) 1988-07-21
EP0116825B1 (de) 1987-12-16
US4579861A (en) 1986-04-01

Similar Documents

Publication Publication Date Title
FI961914A (fi) Lyhytvaikutteiset dihydropyridiinit
ATE224T1 (de) 1,2-dihydro-chinolin-2-on-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
ATE74352T1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ATE88468T1 (de) Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
ATE31410T1 (de) Aryloxypropanolaminderivate, verfahren zu deren herstellung, pharmazeutische praeparate und therapeutische anwendung.
DE3883140T2 (de) Imidazo(2,1-b)benzothiazole und ihre Säureadditionssalze, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zubereitungen.
IE802684L (en) Quinoline derivatives
ES476682A1 (es) Un procedimiento para la preparacion de nuevos dericados de 1-aza-biciclo (2,2,2)octano, utiles como psicotrupos.
SE8503415L (sv) Nya isoindolinylalkylpiperaziner och farmaceutiska kompositioner innehallande desamma
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
DE3264708D1 (en) 4-aryloxy-1,2,3,4-tetrahydroisoquinolines, and intermediates, a process for preparing the same, a pharmaceutical composition containing the same and their use as medicaments
DE3884319D1 (de) Imidazobenzodiazepine und ihre Säureadditionssalze, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zubereitungen.
ATE6635T1 (de) Biologisch aktive trizyklische amine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ES8200662A1 (es) Procedimiento para la preparacion de hidroxifenilcetonas
DE3266521D1 (en) 2-acylaminomethyl-1,4-benzodiazepine derivatives, their preparation and intermediates, and pharmaceutical preparations containing them
ES8800663A1 (es) Procedimiento para preparar compuestos arilsulfonicos.
AU547599B2 (en) Tricyclic compounds
JPS5225736A (en) Preparation of benzamide derivatives
JPS5473751A (en) Phenyl ethanolamine derivatives and their preparation
ATE23155T1 (de) Aminozyklopentanol saeure und ester, ein verfahren zu ihrer herstellung und ihre pharmazeutische zusammensetzung.
ATE914T1 (de) Heterocyclische spiroverknuepfte amidine, ihre stereoisomeren und optischen isomeren, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE17710T1 (de) Keten-0,0-acetale und verfahren zu ihrer herstellung.
IL82419A (en) 3-amino-dihydropyridines,their preparation and medicaments containing them

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties